This study shall determine whether XAPPORT - a mobile device app based on different
guidelines, the summary of product characteristics of rivaroxaban, and clinical facts and
practice - provides adequate guidance to physicians attending patients undergoing elective
surgery, who have to interrupt treatment with rivaroxaban for surgery, in deciding how to
approach the pre- and postoperative management of anticoagulation.